Role of βARK in Long-Term Agonist-Promoted Desensitisation of the β2-Adrenergic Receptor

This publication has 20 references indexed in Scilit:

• Heterogeneity in β-Adrenergic Receptor Kinase Expression in the Lung Accounts for Cell-specific Desensitization of the β2-Adrenergic Receptor
  Published by Elsevier ,1997
• Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding
  Journal of Biological Chemistry, 1996
• Inhaled Corticosteroids Do Not Prevent the Development of Tolerance to the Bronchoprotective Effect of Salmeterol
  Chest, 1996
• Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
  American Journal of Respiratory and Critical Care Medicine, 1995
• Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
  Science, 1995
• Functional effects of long‐term activation on human β₂‐ and β₃‐adrenoceptor signalling
  British Journal of Pharmacology, 1995
• Four Consecutive Serines in the Third Intracellular Loop Are the Sites for β-Adrenergic Receptor Kinase-mediated Phosphorylation and Desensitization of the α2A-Adrenergic Receptor
  Published by Elsevier ,1995
• Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties
  Biochemistry, 1994
• Desensitization of the isolated .beta.2-adrenergic receptor by .beta.-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms
  Biochemistry, 1992
• Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells.
  Proceedings of the National Academy of Sciences, 1988